
Soul Machines
8.0#8 in ai avatar generatorsFrom $140 a yearFree planAndroidiOSWebAPI
Visit

| Fact | Soul Machines | Vidnoz AI |
|---|---|---|
| API authentication | Projects can connect with a web API key or a custom token server that supplies JWT credentials. | API access uses clientId/clientSecret credentials to obtain a bearer access token for requests to devapi.vidnoz.com. |
| Company founding | Crunchbase lists Soul Machines as founded in 2016 by Greg Cross and Mark Sagar. | Vidnoz says it was founded in 2016 and launched Vidnoz AI in 2023. |
| Company legal name | Crunchbase identifies the legal name as Soul Machines Limited. | Crunchbase lists the legal name as Vidnoz and describes the company as active and privately held. |
| Documentation depth | Developer documentation covers Web SDK, Skills API, orchestration, connection setup and technical architecture, with support and knowledge-base articles for Studio. | The public API documentation includes authentication, limits, error-code navigation and endpoint sections for headshots, talking avatars and text-to-avatar. |
| Founded | 2016 | 2016 |
| Integrations | The listed out-of-the-box conversational integrations include Amazon Lex, Google Dialogflow, IBM Watson Assistant, Kore.ai, Microsoft Copilot Studio, Microsoft Azure Bot Service and Voiceflow. | The privacy policy names Google, LinkedIn and Facebook as supported single-sign-on providers. |
| Notable news | An independent October 2026 report states that Soul Machines entered receivership in February 2026 and was sold to AppDirect in September 2026. | Vidnoz announced its ISO/IEC 27001:2022 certification on January 8, 2025. |
| Rating on Capterra | 0.0 out of 5 from 0 reviews. | 4.0 out of 5 from 1 review |
| Rating on G2 | 5.0 out of 5 from 2 reviews. | 4.9 out of 5 from 16 reviews |
Soul Machines may suit businesses building face-to-face AI interactions or Digital Worker workflows across HR, customer experience, IT and sales. Its listed target industries include finance, healthcare, government and pharma.
You want what its maker publishes above — check its page for the details.